Using Botox to Treat Patients With Idiopathic Clubfoot
Primary Purpose
Clubfoot
Status
Unknown status
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Botulinum Toxin (Type A) injection (10 U/Kg)
Sponsored by
About this trial
This is an interventional treatment trial for Clubfoot focused on measuring Idiopathic clubfoot, Botox injection, Idiopathic Talipes Equinovarus, also known as Idiopathic clubfoot
Eligibility Criteria
Inclusion Criteria:
- Idiopathic clubfoot or clubfoot that is not associated with any other neuromuscular disorders or syndromes
Sites / Locations
- BC Children's HospitalRecruiting
Outcomes
Primary Outcome Measures
Surgery rate at any point
Secondary Outcome Measures
Range of motion of treated feet at any follow up
Full Information
NCT ID
NCT00474032
First Posted
May 14, 2007
Last Updated
May 16, 2022
Sponsor
University of British Columbia
1. Study Identification
Unique Protocol Identification Number
NCT00474032
Brief Title
Using Botox to Treat Patients With Idiopathic Clubfoot
Official Title
Efficacy of Botox in Patients With Idiopathic Clubfoot
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Unknown status
Study Start Date
March 2003 (undefined)
Primary Completion Date
March 2023 (Anticipated)
Study Completion Date
March 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of British Columbia
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine the effectiveness of treatment of idiopathic clubfoot utilizing Botulinum Toxin Type A (Botox). This is not a hypothesis-generating study as we are reporting on outcomes of patients who have been treated by this method of clubfoot treatment.
Detailed Description
Subjects with clubfoot will be assessed at the initial visit by Dr. Alvarez. During this visit, the first part of treatment, which is manipulation and casting of the clubfoot will be started. Following this visit, there will be weekly visits for continued manipulation and casting until no further correction of the clubfoot is seen. At this point, (usually after four weeks of casting or when the subject is 6-8 weeks of age), Botox® will be injected into the calf muscles of the affected foot or feet. Before the injection, the patch of skin overlying the intended site(s) of injection will be covered with a local anaesthetic cream (EMLA). This will be applied 30 minutes prior to the injection. This helps numb the skin where the injection will take place. A dose of 10 IU/kg Botox® will be used.
Following the Botox injection another cast will be applied. This will be followed by at least 3 more weekly cast changes to maintain the correction. After the casting and once the child's foot (feet) are big enough and have achieved a minimum of 15 degrees of ankle dorsiflexion with the knee in flexion, the bracing period will begin. This involves use of boots and bars which are worn fulltime until the child begins to weight-bear (usually occurs between 4 to 6 months of age). Until the child reaches skeletal maturity, there will always be a tendency for the foot to return to its clubbed position. Therefore, continued vigilance is part of the care for clubfoot. The following is the appointment schedule, assuming that there are no recurrences:
Weekly appointments for 3 - 5 weeks for initial manipulation and casting
Botox® injection
Weekly appointments for 3 - 4 weeks for casting post Botox® injection or until the foot is big enough to fit in the brace
Weekly appointments for 10 weeks (brace wear at this point)
Monthly appointments for 9 months (brace wear at this point)
Appointments every 6 months until your child reaches 8 years of age
Yearly appointments thereafter until your child reaches 14 years or skeletal maturity
If there is a recurrence of clubfoot malposition, manipulation and casting will be reinstated and a possible repeat of injection of Botox® will be administered.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Clubfoot
Keywords
Idiopathic clubfoot, Botox injection, Idiopathic Talipes Equinovarus, also known as Idiopathic clubfoot
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
2000 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Botulinum Toxin (Type A) injection (10 U/Kg)
Intervention Description
See Detailed Description.
Primary Outcome Measure Information:
Title
Surgery rate at any point
Secondary Outcome Measure Information:
Title
Range of motion of treated feet at any follow up
10. Eligibility
Sex
All
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Idiopathic clubfoot or clubfoot that is not associated with any other neuromuscular disorders or syndromes
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Harpreet Chhina
Phone
604-875-2000
Ext
6008
Email
hchhina@cw.bc.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christine Alvarez, MD
Organizational Affiliation
University of British Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
BC Children's Hospital
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V6H 3V4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Harpreet Chhina
Phone
604-875-2000
Ext
6008
Email
hchhina@cw.bc.ca
12. IPD Sharing Statement
Learn more about this trial
Using Botox to Treat Patients With Idiopathic Clubfoot
We'll reach out to this number within 24 hrs